Auf dieser Seite
HYPD Hyperion DeFi, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$3,73
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,3452-Wochen-Tief
$11,8852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$57M
P/E (TTM)
-0.9
EPS (TTM)
$-4.13
Umsatz (TTM)
$1M
Ihre Abzeichen
52W-Spanne
$2–$12
Analystenbewertung
BUY
Kursziel
$10
P/E
-0.9
ROE
9.6%
Nettogewinnmarge
474.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
HYPD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.73
Marktkapitalisierung (MRQ)
$57M
P/E (TTM)
-0.9
EPS (TTM)
$-4.13
Umsatz (TTM)
$1M
ROE (TTM)
9.6%
Verschuldungsgrad
0.2
52W-Spanne
$2–$12
HYPD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 3. Februar 2025 | 1-for-80 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$813.5K2020-12-31 → 2025-12-31
EPS$-9.402020-12-31 → 2025-12-31
Freier Cashflow·2017-12-31 → 2021-12-31
Nettogewinnmarge474.9%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | HYPD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -0.95-Jahres-Durchschnitt ≈-162.8 | ≈-162.8 | · | · | |
| P/S (TTM) | 40.7 | · | 180.5 | Unterbewertet | |
| K/B (MRQ) | 0.6 | · | 0.9 | Unterbewertet | |
| EV / EBITDA | -0.7 | · | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -2.2 | · | · | · | |
| EV / Revenue (EV / Umsatz) | 42.1 | · | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.85-Jahres-Durchschnitt ≈456.3 | ≈456.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | HYPD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 78.4% | · | · | · | |
| Betriebsgewinnmarge (TTM) | 314.3% | · | -3838.0% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -5743.5% | · | -3573.2% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 474.9% | · | -1237.2% | Spitzenklasse | |
| ROA (TTM) | 7.9% | · | -50.9% | Schwach | |
| ROE (TTM) | 9.6% | · | -26.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | HYPD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Debt / Equity (Fremdkapital / Eigenkapital) | 0.2 | · | 0.0 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 2.3 | · | 3.7 | Geringe Liquidität | |
| Quick Ratio | 2.4 | · | 3.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | HYPD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 1318.8%5-Jahres-Durchschnitt ≈1110.9% | ≈1110.9% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -84.0% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -16.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | HYPD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.0 | · | 0.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$90.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.1%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $0.93 | $4.80 | -80.6% |
| 31. März 2026 | Mai 14, 2026 | $0.26 | $0.14 | 88.8% |
| 31. Dezember 2025 | $-7.76 | $-4.71 | -64.7% | |
| 31. März 2025 | $-1.63 | $-9.79 | 83.4% | |
| 31. Dezember 2024 | $-6.93 | $-7.34 | 5.6% | |
| 30. September 2024 | $-8.80 | $-10.88 | 19.1% | |
| 30. Juni 2024 | $-16.80 | $-12.24 | -37.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $813.5K | $57.3K | $3.8K | · | $14M | $2M | |
| Cost of Revenue | $303.3K | $4M | $16.0K | · | $2M | $800.0K | |
| Gross Profit | $510.2K | $-4M | $-12.2K | · | $12M | $1M | |
| R&D Expense | $2M | $14M | $13M | $13M | $15M | $13M | |
| SG&A Expense | $17M | $14M | $12M | $14M | $11M | $8M | |
| Operating Expenses | $47M | $45M | $25M | $27M | $25M | $21M | |
| Operating Income | $-47M | $-49M | $-25M | $-27M | $-13M | $-20M | |
| Interest Expense | · | · | $2M | $1M | $387.8K | $17.0K | |
| Interest Income | $240.0K | $254.0K | $693.6K | · | · | · | |
| Other Non-op | $389.7K | $-90.6K | $-176.4K | $197.1K | $164.0K | · | |
| Income Tax | $-30.9K | · | · | · | · | · | |
| Net Income | $-45M | $-50M | $-27M | $-28M | $-13M | $-20M | |
| EPS (Basic) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 | $-0.94 | |
| EPS (Diluted) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 | $-0.94 | |
| Shares (Basic) | 5,000,331 | 832,997 | 512,912 | 33,649,747 | 26,324,081 | 21,054,706 | |
| Shares (Diluted) | 5,000,331 | 832,997 | 512,912 | 33,649,747 | 26,324,081 | 21,054,706 | |
| EBITDA | $-47M | · | · | · | $-13M | $-20M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $2M | $15M | $23M | $19M | $28M | |
| Inventory | · | · | $109.8K | · | · | · | |
| Prepaid Expense | $934.9K | $645.7K | $1M | $1M | $734.9K | $453.5K | |
| Other Current Assets | $404.4K | $97.3K | · | · | · | · | |
| Current Assets | $7M | $3M | $21M | $28M | $22M | $33M | |
| PP&E (Net) | · | · | $3M | $1M | $1M | $396.4K | |
| PP&E (Gross) | · | $6M | $5M | $2M | $2M | $573.3K | |
| Accum. Depreciation | · | $3M | $1M | $635.8K | $328.4K | $176.9K | |
| Intangibles | · | · | $2M | · | · | · | |
| Other Non-current Assets | $230.4K | $182.2K | · | · | · | · | |
| Total Assets | $52M | $4M | $29M | $31M | $32M | $34M | |
| Accounts Payable | $317.9K | $2M | $2M | $1M | $2M | $1M | |
| Short-term Debt | $8M | $11M | $6M | $416.7K | · | $97.5K | |
| Current Liabilities | $3M | $16M | $10M | $5M | $11M | $18M | |
| Capital Leases | $206.6K | $717.5K | $1M | $907.6K | · | · | |
| Total Liabilities | $11M | $17M | $20M | $14M | $11M | $19M | |
| Total Debt | $8M | · | · | · | · | $97.5K | |
| Common Stock | · | $151 | $57 | $3.7K | $2.8K | $2.5K | |
| Paid-in Capital | $282M | $182M | $154M | $135M | $111M | $93M | |
| Retained Earnings | $-241M | $-195M | $-145M | $-118M | $-90M | $-77M | |
| Treasury Stock | $253.6K | · | $5M | $0 | · | · | |
| Stockholders' Equity | $41M | $-13M | $9M | $17M | $20M | $15M | |
| Liabilities + Equity | $52M | $4M | $29M | $31M | $32M | $34M | |
| Shares Outstanding | 8,680,005 | 1,506,369 | 569,409 | 36,668,980 | 28,426,616 | 24,978,585 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | $1M | $783.2K | $307.4K | $221.6K | $95.4K | |
| Stock-based Comp | $6M | $2M | $2M | $4M | $3M | $2M | |
| Other Non-cash | · | · | · | · | $-11M | $11M | |
| Operating Cash Flow | $-15M | $-30M | $-24M | $-25M | $-21M | $-6M | |
| CapEx | · | $161.5K | $3M | $540.4K | $1M | $261.3K | |
| Investing Cash Flow | $-72M | $-161.5K | $-4M | $-874.7K | $-2M | $-261.3K | |
| Net Debt Issued | · | · | · | · | $-66.6K | · | |
| Stock Issued | · | · | · | · | · | $13M | |
| Net Stock Activity | · | · | · | · | · | $13M | |
| Financing Cash Flow | $91M | $18M | $20M | $22M | $21M | $21M | |
| Net Change in Cash | $4M | $-13M | $-8M | $-4M | $-1M | $14M | |
| Taxes Paid | $-8.1K | $36.1K | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-22M | $-7M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 62.7% | · | · | · | 88.6% | 60.0% | |
| Operating Margin | -5743.5% | · | · | · | -92.2% | -989.5% | |
| Net Margin | -5570.6% | · | · | · | -91.3% | -988.5% | |
| EBITDA Margin | -5743.5% | · | · | · | -90.6% | -984.7% | |
| ROA | -163.5% | · | · | · | -39.0% | -81.3% | |
| ROE | -115.6% | · | · | · | -103.4% | -116.5% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | · | · | · | 2.0 | 1.8 | |
| Quick Ratio | 2.4 | · | · | · | 1.7 | 1.6 | |
| Debt / Equity | 0.2 | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | -33.3 | -1161.2 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.4 | 0.1 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.73 | · | · | · | $0.72 | $0.61 | |
| Revenue / Share | $0.16 | · | · | · | $0.53 | · | |
| Cash Flow / Share | $-2.95 | · | · | · | $-0.79 | · | |
| Cash / Share | $0.74 | · | · | · | $0.68 | $1.14 | |
| EPS (TTM) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 | $-0.94 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 1318.8% | 1414.0% | · | · | 600.0% | · | |
| Revenue CAGR 3Y | · | -84.0% | -87.6% | · | · | · | |
| Revenue CAGR 5Y | -16.5% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $813.5K | $57.3K | $3.8K | $0 | $14M | $2M | |
| Net Income TTM | $-45M | $-50M | $-27M | $-28M | $-13M | $-20M | |
| Market Cap | $31M | · | · | · | $9.10B | $12.11B | |
| Enterprise Value | $33M | · | · | · | · | $12.08B | |
| P/E | -0.4 | -0.2 | -3.1 | -157.1 | -653.1 | -515.7 | |
| P/S | 38.0 | · | · | · | 649.8 | 6054.8 | |
| P/B | 0.8 | · | · | · | 444.5 | 791.3 | |
| P / Tangible Book | 0.8 | · | 1102.4 | 277.4 | 444.5 | 791.3 | |
| P / Cash Flow | -2.1 | · | · | · | -435.8 | -1896.8 | |
| P / FCF | · | · | · | · | -411.6 | -1822.2 | |
| EV / EBITDA | -0.7 | · | · | · | · | -613.5 | |
| EV / FCF | · | · | · | · | · | -1818.0 | |
| EV / Revenue | 40.3 | · | · | · | · | 6040.7 | |
| Earnings Yield | -264.0% | -512.1% | -31.9% | -0.64% | -0.15% | -0.19% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $357.7K | $244.3K | $496.2K | $302.5K | $0 | $14.7K | $28.1K | $1.6K | $22.6K | $5.0K | $2.6K | $1.2K | · | · | · | $0 | |
| Cost of Revenue | · | · | $303.2K | $0 | $0 | $48 | $3M | $132.5K | $490.4K | $203.0K | $2.6K | $13.4K | · | · | · | $0 | |
| Gross Profit | $357.7K | $244.3K | $193.0K | $302.5K | $0 | $14.7K | $-3M | $-130.9K | $-467.7K | $-198.0K | $0 | $-12.2K | · | · | · | $0 | |
| R&D Expense | $58.5K | $286.8K | $189.0K | $373.9K | $674.6K | $673.0K | $2M | $3M | $5M | $4M | $4M | $4M | $3M | $3M | $2M | $4M | |
| SG&A Expense | $4M | $4M | $5M | $3M | $8M | $2M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $-31M | $-8M | $40M | $-4M | $8M | $3M | $16M | $7M | $11M | $10M | $7M | $7M | $6M | $5M | $5M | $7M | |
| Operating Income | $31M | $9M | $-40M | $4M | $-8M | $-3M | $-19M | $-7M | $-12M | $-10M | $-7M | $-7M | $-6M | $-5M | $-5M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $678.7K | · | $679.2K | $558.0K | $454.0K | $904.2K | $177.1K | |
| Interest Income | $206.8K | $244.2K | $138.9K | $43.9K | $21.9K | $35.3K | $23.2K | $45.0K | $64.9K | $120.9K | $198.7K | $208.9K | $183.6K | · | · | · | |
| Other Non-op | $-29.8K | $90.1K | $85.6K | $131.5K | $168.8K | $3.7K | $2.8K | $1.2K | $3.0K | $-97.6K | $-18.6K | $-348.2K | $119.5K | $71.0K | $100.5K | $70.3K | |
| Net Income | $31M | $9M | $-40M | $7M | $-9M | $-3M | $-20M | $-8M | $-11M | $-11M | $-8M | $-7M | $-6M | $-6M | $-6M | $-7M | |
| EPS (Basic) | $1.01 | $0.30 | $-5.57 | $0.26 | $-2.50 | $-1.59 | $-15.34 | $-9.07 | $-16.65 | $-18.75 | $-52.66 | $-0.18 | $-0.16 | $-0.15 | $-0.16 | $-0.21 | |
| EPS (Diluted) | $0.92 | $0.26 | $-5.36 | $0.05 | $-2.50 | $-1.59 | $-15.34 | $-9.07 | $-16.65 | $-18.75 | $-52.66 | $-0.18 | $-0.16 | $-0.15 | $-0.16 | $-0.21 | |
| Shares (Basic) | 14,173,457 | 10,610,679 | · | 6,027,713 | 3,518,906 | 2,188,938 | · | 869,479 | 664,022 | 582,584 | · | 40,139,697 | 38,093,826 | 37,410,587 | · | 34,631,774 | |
| Shares (Diluted) | 17,040,392 | 12,686,142 | · | 28,951,915 | 3,518,906 | 2,188,938 | · | 869,479 | 664,022 | 582,584 | · | 40,139,697 | 38,093,826 | 37,410,587 | · | 34,631,774 | |
| EBITDA | $31M | $9M | · | $4M | $-8M | $-3M | · | $-7M | $-12M | $-10M | · | $-7M | $-6M | $-5M | · | $-7M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $7M | $6M | $8M | $8M | $4M | $2M | $7M | $2M | $8M | $15M | $21M | $17M | $18M | $23M | $17M | |
| Inventory | · | · | · | · | · | · | · | $3M | $3M | $4M | $109.8K | $50.3K | · | · | · | · | |
| Prepaid Expense | $3M | $1M | $802.3K | $862.6K | $967.0K | $1M | $645.7K | $987.8K | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $221.2K | $120.0K | $201.6K | · | $80.1K | · | $97.3K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $13M | $9M | $7M | $9M | $9M | $5M | $3M | $12M | $7M | $14M | $21M | $27M | $23M | $25M | $28M | $29M | |
| PP&E (Net) | · | · | · | · | $23.0K | · | · | $3M | $3M | $3M | $3M | $4M | $4M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $5M | $5M | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $1M | $1M | · | · | $635.8K | · | |
| Intangibles | · | · | · | · | · | · | · | $6M | $6M | $6M | $2M | $2M | · | · | · | · | |
| Other Non-current Assets | $182.2K | $182.2K | $230.4K | $238.0K | · | · | $182.2K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $113M | $70M | $52M | $83M | $56M | $6M | $4M | $23M | $19M | $26M | $29M | $35M | $29M | $29M | $31M | $31M | |
| Accounts Payable | $139.1K | $428.3K | $317.9K | $1M | $901.6K | $1M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Accrued Liabilities | · | $4.6K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | $8M | $8M | $8M | $11M | $11M | $10M | $10M | $9M | $6M | $3M | $1M | $2M | $416.7K | · | |
| Current Liabilities | $6M | $4M | $3M | $4M | $10M | $15M | $16M | $16M | $16M | $16M | $10M | $7M | $4M | $5M | $5M | $11M | |
| Capital Leases | $55.6K | $132.4K | $206.6K | $341.8K | $473.2K | $597.7K | $717.5K | $836.4K | $983.8K | $1M | $1M | $1M | $2M | $1M | $907.6K | · | |
| Total Liabilities | $11M | $12M | $11M | $12M | $18M | $16M | $17M | $19M | $21M | $24M | $20M | $19M | $19M | $13M | $14M | $11M | |
| Total Debt | · | · | · | $8M | $8M | $11M | · | $10M | $10M | $9M | · | $3M | $1M | $2M | · | · | |
| Common Stock | · | · | · | $715 | $485 | $283 | · | $8.6K | $5.6K | $4.7K | $57 | $4.3K | $3.8K | $3.8K | $3.7K | $3.6K | |
| Paid-in Capital | $303M | $290M | $282M | $272M | $245M | $189M | $182M | $179M | $165M | $158M | $154M | $153M | $141M | $140M | $135M | $132M | |
| Retained Earnings | $-201M | $-232M | $-241M | $-201M | $-207M | $-199M | $-195M | $-175M | $-167M | $-156M | $-145M | $-138M | $-130M | $-124M | $-118M | $-112M | |
| Treasury Stock | · | · | $253.6K | · | · | · | · | $0 | $0 | $2M | · | $5M | $4M | $16M | $0 | · | |
| Stockholders' Equity | $102M | $58M | $41M | $71M | $37M | $-10M | $-13M | $4M | $-2M | $2M | $9M | $16M | $11M | $16M | $17M | $20M | |
| Liabilities + Equity | $113M | $70M | $52M | $83M | $56M | $6M | $4M | $23M | $19M | $26M | $29M | $35M | $29M | $29M | $31M | $31M | |
| Shares Outstanding | 15,299,832 | 11,428,482 | 8,680,005 | 7,162,659 | 4,854,827 | 2,830,546 | 1,506,369 | 86,375,958 | 55,817,921 | 47,386,349 | 569,409 | 42,898,246 | 38,169,398 | 37,991,746 | 36,668,980 | 35,525,689 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $297.8K | $287.5K | $295.4K | $247.7K | $277.5K | $318.4K | $124.1K | $63.1K | $78.5K | $83.0K | |
| Stock-based Comp | $2M | $2M | · | · | $6M | $279.6K | $164.0K | $453.0K | $541.1K | $546.2K | $572.2K | $613.0K | $493.6K | $819.1K | $890.7K | $928.7K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $236.4K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-6M | $-6M | $-8M | $-10M | $-6M | $-6M | $-5M | $-7M | $-5M | $-7M | |
| CapEx | · | · | · | · | · | · | $1 | $1.6K | $45.7K | $114.1K | $145.2K | $580.2K | $1M | $920.9K | $31.0K | $228.0K | |
| Investing Cash Flow | $-5M | $-1M | $-6M | $-20M | · | · | $-1 | $-1.6K | $-45.7K | $-114.1K | $-145.2K | $-2M | $-1M | $-838.1K | $-311.8K | $-163.3K | |
| Financing Cash Flow | $11M | $7M | $9M | $24M | $53M | $6M | $1M | $11M | $3M | $3M | $614.3K | $11M | $5M | $3M | $3M | $3M | |
| Net Change in Cash | $2M | $937.5K | $-2M | $690.9K | $4M | $2M | $-5M | $5M | $-6M | $-7M | $-6M | $3M | $-998.2K | $-4M | $-2M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-10M | · | · | · | $-8M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | · | 100.0% | · | 99.7% | · | -8055.2% | -2067.3% | · | · | · | · | · | · | · | |
| Operating Margin | 8668.8% | 3574.8% | · | 1463.8% | · | -20589.0% | · | -451195.5% | -51661.2% | -205624.4% | · | -544255.9% | · | · | · | · | |
| Net Margin | 8652.9% | 3619.2% | · | 2190.2% | · | -23665.3% | · | -485406.3% | -48856.1% | -218748.3% | · | -612582.0% | · | · | · | · | |
| EBITDA Margin | 8668.8% | 3574.8% | · | 1463.8% | · | -20589.0% | · | -451195.5% | -51661.2% | -200662.9% | · | -544255.9% | · | · | · | · | |
| ROA | 36.7% | 23.2% | · | 12.6% | -23.3% | -21.7% | · | -27.4% | -45.7% | -39.4% | · | -22.1% | -19.1% | -16.5% | · | -25.9% | |
| ROE | 44.4% | 36.2% | · | 17.8% | -49.7% | 88.2% | · | -80.9% | -271.2% | -123.9% | · | -40.6% | -36.4% | -25.2% | · | -59.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.0 | · | 2.3 | 0.9 | 0.3 | · | 0.7 | 0.5 | 0.9 | · | 4.1 | 5.7 | 5.1 | · | 2.7 | |
| Quick Ratio | 1.7 | 1.7 | · | 2.0 | 0.7 | 0.3 | · | 0.5 | 0.1 | 0.5 | · | 3.2 | 4.3 | 3.8 | · | 1.6 | |
| Debt / Equity | · | · | · | 0.1 | 0.2 | -1.1 | · | 2.7 | -4.3 | 4.8 | · | 0.2 | 0.1 | 0.1 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -15.1 | · | -9.6 | -10.7 | -12.0 | · | -40.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.1 | 0.3 | 0.0 | · | 0.0 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $5.12 | · | $9.88 | $7.70 | $-3.43 | · | $0.04 | $-0.04 | $0.04 | · | $0.37 | $0.28 | $0.42 | · | $0.57 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.01 | · | $0.01 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.33 | · | · | · | $-2.03 | · | · | · | $-0.21 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.63 | $0.65 | · | $1.15 | $1.55 | $1.39 | · | $0.08 | $0.04 | $0.17 | · | $0.48 | $0.46 | $0.49 | · | $0.49 | |
| EPS (TTM) | $-4.13 | $-7.55 | · | $-19.38 | $-28.50 | $-42.65 | · | $-97.13 | $-88.24 | $-71.75 | · | $-0.65 | $-0.68 | $-0.74 | · | $-0.55 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $345.3K | $44.4K | $67.1K | · | $31.8K | $31.4K | · | · | · | $10M | $10M | · | $10M | |
| Net Income TTM | $7M | $-33M | · | $-26M | $-40M | $-42M | · | $-38M | $-37M | $-32M | · | $-25M | $-25M | $-26M | · | $-19M | |
| Market Cap | $48M | $39M | · | $69M | $50M | $3M | · | $3.57B | $2.65B | $3.74B | · | $5.70B | $7.24B | $10.73B | · | $5.56B | |
| Enterprise Value | · | · | · | $69M | $51M | $10M | · | $3.58B | $2.66B | $3.74B | · | $5.68B | $7.22B | $10.71B | · | · | |
| P/E | -0.8 | -0.5 | · | -0.5 | -0.4 | -0.0 | · | -0.4 | -0.5 | -1.1 | · | -204.3 | -278.8 | -381.6 | · | -284.4 | |
| P/S | 34.3 | 37.8 | · | 198.7 | 1134.0 | 46.4 | · | 112230.1 | 84460.0 | · | · | · | 723.7 | 1072.9 | · | 555.6 | |
| P/B | 0.5 | 0.7 | · | 1.0 | 1.3 | -0.3 | · | 960.5 | -1119.2 | 2056.3 | · | 361.0 | 687.8 | 678.4 | · | 273.3 | |
| P / Tangible Book | 0.5 | 0.7 | · | 1.0 | 1.3 | · | · | · | · | · | · | 417.1 | 687.8 | 678.4 | · | 273.3 | |
| P / Cash Flow | · | -9.4 | · | · | · | -0.7 | · | · | · | -377.9 | · | · | · | -1541.8 | · | · | |
| EV / Revenue | · | · | · | 198.8 | 1148.4 | 148.6 | · | 112320.5 | 84713.3 | · | · | · | 722.0 | 1071.3 | · | · | |
| Earnings Yield | -131.5% | -218.8% | · | -202.3% | -274.6% | -3877.3% | · | -234.8% | -185.7% | -91.0% | · | -0.49% | -0.36% | -0.26% | · | -0.35% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $813.5K | $57.3K | $3.8K | · | $14M |
| Bruttogewinnmarge % | 62.7% | · | · | · | 88.6% |
| Betriebsgewinnmarge % | -5743.5% | · | · | · | -92.2% |
| Nettoergebnis | $-45M | $-50M | $-27M | $-28M | $-13M |
| Verwässerte EPS | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | · | · | · | · |
| Liquiditätsgrad | 2.7 | · | · | · | 2.0 |
| Quick Ratio | 2.4 | · | · | · | 1.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | · | $-22M |
Institutionelle Eigentümer (13F) 37 Einreicher · $11.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
37
Gehaltener Wert
$11.2M
Neue Positionen
10
Geschlossene Positionen
5
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 10 (+4 vs. Vorquartal) | 5 (-1 vs. Vorquartal) | 9 (+3 vs. Vorquartal) | 6 (+1 vs. Vorquartal) | +1.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| LASRY MARC | $2.300.388 | 240.124 | 20,47% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.465.746 | 466.798 | 13,05% | Aktien |
| FRANKLIN RESOURCES INC | $1.243.248 | 395.939 | 11,07% | Aktien |
| Arrington Capital Management, LLC | $935.020 | 297.777 | 8,32% | Aktien |
| MORGAN STANLEY | $747.276 | 237.986 | 6,65% | Aktien |
| Redwood Wealth Management Group, LLC | $632.292 | 183.273 | 5,63% | Aktien |
| Almanack Investment Partners, LLC. | $530.701 | 169.013 | 4,72% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $410.467 | 130.707 | 3,65% | Aktien |
| JANE STREET GROUP, LLC | $400.321 | 127.491 | 3,56% | Aktien |
| OPPENHEIMER & CO INC | $396.786 | 126.365 | 3,53% | Aktien |
| BlackRock, Inc. | $359.216 | 114.400 | 3,20% | Aktien |
| VANGUARD GROUP INC | $306.373 | 86.060 | 2,73% | Aktien |
| GOLDMAN SACHS GROUP INC | $286.965 | 91.390 | 2,55% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $233.789 | 74.455 | 2,08% | Aktien |
| CITADEL ADVISORS LLC | $176.779 | 56.299 | 1,57% | Aktien |
| STATE STREET CORP | $170.681 | 54.357 | 1,52% | Aktien |
| Cubist Systematic Strategies, LLC | $140.290 | 14.644 | 1,25% | Aktien |
| UBS Group AG | $104.182 | 33.179 | 0,93% | Aktien |
| NORTHERN TRUST CORP | $97.013 | 30.896 | 0,86% | Aktien |
| PEAK6 LLC | $62.800 | 20.000 | 0,56% | Aktien |
| INVESTMENT HOUSE LLC | $54.322 | 17.300 | 0,48% | Aktien |
| JPMORGAN CHASE & CO | $51.220 | 16.107 | 0,46% | Aktien |
| XTX Topco Ltd | $38.587 | 12.289 | 0,34% | Aktien |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | $34.933 | 11.125 | 0,31% | Aktien |
| Sanctuary Advisors, LLC | $33.912 | 10.800 | 0,30% | Aktien |
| BARCLAYS PLC | $5.674 | 1.807 | 0,05% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $5.410 | 1.768 | 0,05% | Aktien |
| WELLS FARGO & COMPANY/MN | $3.862 | 1.230 | 0,03% | Aktien |
| SBI Securities Co., Ltd. | $3.828 | 1.219 | 0,03% | Aktien |
| Tower Research Capital LLC (TRC) | $2.675 | 852 | 0,02% | Aktien |
| Vanguard Global Advisers, LLC | $311 | 99 | 0,00% | Aktien |
| 10Elms LLP | $283 | 90 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $170 | 54 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $65 | 20.500 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $13 | 4 | 0,00% | Aktien |
| CITIGROUP INC | $3 | 1 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $3 | 1 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Avenue Venture Opportunities Fund, L.P., Avenue Venture Opportunities Fund II, L.P., Avenue Capital Management II, L.P., Avenue Venture Opportunities Partners, LLC, Avenue Venture Opportunities Partners II, LLC, GL Venture Opportunities Partners, LLC, GL Venture Opportunities Partners II, LLC, Marc Lasry ×7 Einreichungen | 19. September 2025 | 4,20% | Änderung | · | SEC |
| Hyunsu Jung | 16. Juli 2025 | 9,30% | Erste Einreichung | Passive Anlage | SEC |
| Stuart M. Grant ×7 Einreichungen | 4. Dezember 2024 | · | Erste Einreichung | · | SEC |
| Tsontcho Ianchulev ×8 Einreichungen | 18. Juli 2024 | · | Erste Einreichung | · | SEC |
| Fred Eshelman ×5 Einreichungen | 13. Februar 2023 | · | Erste Einreichung | · | SEC |
| Shuhei Yoshida, Senju Pharmaceutical Co., Ltd. ×2 Einreichungen | 24. August 2021 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 26 Insider · 9 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Hyunsu Jung | Chief Executive Officer and Chief Investment Officer | 16. August 2026 F | 1.345.676 | 4 | 0 | $29.580 |
| Michael M Rowe | Chief Executive Officer | 13. Juni 2025 A | 7.975 | 0 | 0 | $0 |
| David R. Knox | Chief Financial Officer | 29. September 2026 F | 287.556 | 1 | 0 | $100.340 |
| Andrew D. Jones | Chief Financial Officer | 30. August 2024 A | · | 0 | 0 | $0 |
| John P Gandolfo | Chief Financial Officer | 12. Februar 2024 A | 8.000 | 0 | 0 | $0 |
| Bren Kern | Chief Operating Officer | 21. April 2025 A | 50.031 | 0 | 0 | $0 |
| Robert Rubenstein | General Counsel | 12. Januar 2026 A | 75.000 | 0 | 0 | $0 |
| Jennifer G Clasby | VP, Regulatory and Clinical | 17. Juni 2021 M | 66.537 | 0 | 0 | $0 |
| Luke Clauson | VP Research & Development | 16. Juni 2021 A | · | 0 | 0 | $0 |
| Rachel Jacobson | Direktor | 30. Juni 2026 A | 115.218 | 0 | 0 | $0 |
| Happy David Walters | Direktor | 30. Juni 2026 A | 170.847 | 1 | 0 | $187.029 |
| Ellen R Strahlman | Direktor | 30. Juni 2026 A | 150.078 | 6 | 0 | $233.797 |
| Michael S Geltzeiler | Direktor | 30. Juni 2026 A | 146.932 | 1 | 0 | $90.300 |
| Ram Palanki | Direktor | 21. April 2025 A | 4.235 | 0 | 0 | $0 |
| Tsontcho Ianchulev | Direktor | 21. April 2025 A | 10.122 | 0 | 0 | $0 |
| Charles E Mather IV | Direktor | 21. April 2025 A | 9.950 | 0 | 0 | $0 |
| Julia A Haller | Direktor | 16. Juni 2022 A | 30.408 | 0 | 0 | $0 |
| Kenneth B Lee JR | Direktor | 16. Juni 2022 A | 64.544 | 0 | 0 | $0 |
| Stephen Keith Benjamin | Direktor | 11. April 2022 A | 25.511 | 0 | 0 | $0 |
| Curt H Labelle | Direktor | 17. November 2021 A | 42.236 | 0 | 0 | $0 |
| Anthony Y Sun | Direktor | 17. November 2021 A | 26.322 | 0 | 0 | $0 |
| Ernest Mario | Direktor | 17. November 2021 A | 382.706 | 0 | 0 | $0 |
| Fredric N Eshelman | Direktor | 17. November 2021 A | 1.299.750 | 0 | 0 | $0 |
| Shuhei Yoshida | Direktor | 14. Mai 2019 M | 33.334 | 0 | 0 | $0 |
| Stuart M. Grant | 10%-Eigentümer | 2. Juli 2024 J | 10.914.153 | 0 | 0 | $0 |
| Senju Pharmaceutical Co., Ltd. | 10%-Eigentümer | 29. Januar 2018 P | 1.718.566 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SATO · Invesco Exchange-Traded Fund Trust … | 2,12% | 47.988 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,01% | 33.775 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 176.041 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 290.757 SH | 19. August 2026 | Täglich |
HYPD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$9.82
+163,4%
2 25,0%
Starker Kauf
5 62,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-01Mittelwert-Ziel $9.82 +163,4%
← Unter allen Zielen
Aktueller Preis $3.73
Tief$8.45
Mittelwert$9.82
Hoch$11.20
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| CING | · | · | · | · | · | · |
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| ELOX | · | · | · | · | 30.1% | · |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026